7-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid | 1352395-45-9

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 吡唑并吡啶类
• 英文名称: 7-Methoxypyrazolo[1,5-a]pyridine-3-carboxylic acid
• CAS: 1352395-45-9
• 化学式: C₉H₈N₂O₃
• 分子量: 192.17
• InChiKey: DFTMUTQRNVENKC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.9
• 重原子数：
  14
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.11
• 拓扑面积：
  63.8
• 氢给体数：
  1
• 氢受体数：
  4

文献信息

• Monoacylglycerol Lipase Modulators
  申请人：Janssen Pharmaceutica NV

  公开号：US20200102303A1

  公开（公告）日：2020-04-02

  Fused compounds of Formula (I) and Formula (II), pharmaceutical compositions containing them, methods of making them, and methods of using them including methods for treating disease states, disorders, and conditions associated with MGL modulation, such as those associated with pain, psychiatric disorders, neurological disorders (including, but not limited to major depressive disorder, treatment resistant depression, anxious depression, bipolar disorder), cancers and eye conditions. Wherein R 1 , R 2 , R 2a , R 3 , R 3a , R 4 , and R 4a are defined herein.

  化合物的结构式（I）和结构式（II），含有它们的药物组合物，制备它们的方法，以及使用它们的方法，包括用于治疗与MGL调节相关的疾病状态、紊乱和病况的方法，例如与疼痛、精神障碍、神经障碍（包括但不限于重性抑郁障碍、治疗抵抗性抑郁症、焦虑性抑郁症、躁郁症）、癌症和眼部疾病相关的方法。 其中R1、R2、R2a、R3、R3a、R4和R4a在此处定义。
• [EN] N-CYCLOBUTYL-IMIDAZOPYRIDINE OR -PYRAZOLOPYRIDINE CARBOXAMIDES AS TRPV1 ANTAGONISTS<br/>[FR] CARBOXAMIDES DE N-CYCLO-BUTYLIMIDAZOPYRIDINE OU DE N-CYCLO-PYRAZOLOPYRIDINE COMME ANTAGONISTES DE TRPV1
  申请人：GLAXO GROUP LTD

  公开号：WO2012072512A1

  公开（公告）日：2012-06-07

  A compound of formula (I) wherein X1 represents a hydrogen atom, or a CH2OH group X2 represents a hydrogen atom, a fluorine atom, an OCH3 group or a CH2OH group, and at least one of X1 and X2 is hydrogen Y represents a carbon atom and Z represents a nitrogen atom or Y represents a nitrogen atom and Z represents a carbon atom; R1 represents a halogen atom, a C1-4 alkyl group, a trifluoromethyl group or a trifluoromethoxy group, and R2 are R3 each independently selected from a hydrogen atom, a halogen atom, a C1-4 alkyl group, a trifluoromethyl group or a trifluoromethoxy group; or a pharmaceutically acceptable salt or solvate thereof.

  式（I）的化合物，其中X1代表氢原子或CH2OH基团，X2代表氢原子、氟原子、OCH3基团或CH2OH基团，X1和X2中至少有一个为氢，Y代表碳原子，Z代表氮原子或Y代表氮原子，Z代表碳原子；R1代表卤素原子、C1-4烷基基团、三氟甲基基团或三氟甲氧基团，R2和R3各自独立地选自氢原子、卤素原子、C1-4烷基基团、三氟甲基基团或三氟甲氧基团；或其药用可接受的盐或溶剂。